Novartis reported $4.13B in Pre-Tax Profit for its second fiscal quarter of 2022.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Pre Tax Profit Change
AstraZeneca AZN:LN USD 3.09B 52M
Biogen BIIB:US USD 821M 53.8M
Canopy Growth Corp WEED:CN CAD -223691000 1.86B
GlaxoSmithKline GSK:LN GBP 2.43B 602M
Horizon Pharma HZNP:US USD 315.1M 27.58M
Johnson & Johnson JNJ:US USD 8.07B 98M
Novartis NOVN:VX USD 4.06B 72M
Pfizer PFE:US USD 10.67B 3.11B
Roche Holding ROG:VX 12.11B 2.43B
Supernus Pharmaceuticals SUPN:US USD -444000 11.77M
Teva Pharmaceutical Industries TEVA:US USD 769M 62M
Valeant Pharmaceuticals VRX:CN USD 329M 92M